TITLE

PLATELET INHIBITORS

PUB. DATE
January 2007
SOURCE
Complete Guide to Prescription & Nonprescription Drugs 2012;2007, p672
SOURCE TYPE
Encyclopedia
DOC. TYPE
Article
ABSTRACT
The article presents information on platelet inhibitors, the antithrombotic agents used for reducing the risk of heart attack or stroke. The dosage and usage information is provided. The possible adverse reactions or side effects of the drugs, warnings, and precautions are discussed. Possible interaction of the drugs with other drugs is also mentioned.
ACCESSION #
23970573

 

Related Articles

  • AN EVALUATION OF FIBRINOLYSIN THERAPY IN ACUTE MYOCARDIAL INFARCTION. Richter, Isaac H.; Epstein, Samuel; Cliffton, Eugene // Angiology;Feb1969, Vol. 20 Issue 2, p95 

    In 182 hospitalized patients given fibrinolysin and anticoagulants, the rate of mortality following acute myocardial infarction was lower than the rate observed with anticoagulants alone. One million or more M.S.D. units of fibrinolysin was the most effective dose studied for maximum improvement...

  • PLATELET INHIBITORS.  // Complete Guide to Prescription & Nonprescription Drugs 2012;2008, p670 

    The article presents information on platelet inhibitors, the antithrombotic agents used for reducing the risk of heart attack or stroke. The dosage and usage information is provided. The possible adverse reactions or side effects of the drugs, warnings, and precautions are discussed. Possible...

  • Dabigatran associated with increased MI risk.  // Pulse;1/18/2012, Vol. 72 Issue 2, p13 

    The article offers information on the results of a new meta-analysis headed by neurologist Dr. Ken Uchino which highlight the association of anticoagulant dabigatran with an increased risk of myocardial infarction (MI) or acute coronary syndrome.

  • Blood Thinners and Your Brain.  // Mind, Mood & Memory;Nov2014, Vol. 10 Issue 11, p6 

    The article focuses on the proper use of blood thinners or antithrombotic medications. Topics discussed include the use of antithrombotics for preventing heart attacks and brain-damaging strokes and the emergence of a new generation of oral anticoagulants. Also mentioned are the risk of bleeding...

  • Aspirin withdrawal.  // Reactions Weekly;4/11/2009, Issue 1247/1248, p7 

    The article describes the case of a 65-year-old man with a history of inferior stent thrombosis (ST)-elevation myocardial infarction (STEMI) who developed very late thrombosis of a bare metal stent after discontinuing aspirin antiplatelet therapy. He received intracoronary abciximab and...

  • Fluvastatin: A Review of its Use in Lipid Disorders. Langtry, H.D.; Markham, A. // Drugs;Apr1999, Vol. 57 Issue 4, p583 

    Fluvastatin is an HMG-CoA reductase inhibitor used to treat patients with hypercholesterolaemia. Since fluvastatin was last reviewed in Drugs, trials have shown its efficacy in the secondary prevention of coronary heart disease (CHD) events and death and have expanded knowledge of its effects in...

  • Fixed-Dose Combination Therapy with Statins: Strengths, Limitations, and Clinical and Regulatory Considerations. Hennekens, Charles H. // American Journal of Cardiovascular Drugs;2008, Vol. 8 Issue 3, p155 

    The obvious strengths of fixed-dose drug combinations include the potential advantages of increased compliance, convenience, and cost savings. In contrast, potential disadvantages include reduced flexibility in dosing, exposure of some patients to therapies they do not require, and possible...

  • PHARMACOTHERAPEUTICAL STUDY OF MYOCARDIAL INFARCTION. Ziauddin; Ali, N.; Sultan, U.; Haq, Z. // Canadian Journal of Applied Sciences;Mar2012, Vol. 2 Issue 1, p233 

    Myocardial Infarction arises due to disruption of balance between supply and demand of blood to the heart muscles, and is a leading cause of death all around the World. This study was conducted on patients data collected in "Cardiac Care Unit and Cardiology Ward" one of the leading hospital in...

  • Anticoagulation. Fitzmaurice, David; Spink, Julian // Pulse;4/14/2010, Vol. 70 Issue 12, p19 

    The article presents questions and answers related to warfarin including how it will initiate, its management and interactions.

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics